Highnoon Laboratories 9MCY26 profit remains nearly flat
Mettis Global • • 1 min read
Highnoon Laboratories reported profit after tax of Rs2.71 billion for the nine months to September 30, 2026, up 1.25% from Rs2.68 billion a year earlier. Earnings per share also advanced 1.25%, reaching Rs51.22 compared with Rs50.59, according to Mettis Global.
Revenue increased 5.85% to Rs21.49 billion, while gross profit grew 10.31% to Rs12.35 billion and operating profit rose 12.83% to Rs4.53 billion. Lower finance costs helped, but taxation climbed 29.47% to Rs2.02 billion, other operating expenses more than doubled to Rs469.94 million, and other income fell 13.87%, limiting the increase in final earnings. The results show stronger operating performance but little year-on-year change in the pharmaceutical company’s bottom line.
At a glance
- Nine-month net profit increased 1.25% to Rs2.71 billion.
- Revenue grew 5.85% to Rs21.49 billion.
- Taxation rose 29.47% to Rs2.02 billion.
Stocks in this story
Originally reported by Mettis Global
This page is Investify's own summary. The full report, with all details and context, is on the publisher's site.
Read the full storyWant the full article here?
Log in to read the full article in the Investify reader, in English or Urdu.
Investify summarizes Pakistan Stock Exchange news in its own words and links each story to its original publisher. We always credit the source so you can read the full report and verify the details before making financial decisions.
More on HINOON
PICT 9MCY26 profit falls 30%Mettis• 27 Oct 2026
Loads Limited to establish Rs200m manufacturing facility in LahoreMettis• 27 Oct 2026
TBL 1QFY27 net loss widens 65%Mettis• 27 Oct 2026
Pakistan plans $2.25 billion battery gigafactory as demand projected to hit 100,000 MW in four years: reportProfit• 27 Oct 2026
Loads Limited to set up Rs200 million manufacturing facility in LahoreProfit• 27 Oct 2026
Pakistan’s freelance earnings surge 46% to $550 million in Q1 FY27Profit• 27 Oct 2026
